Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method

Therapeutic Drug Monitoring

Volumn 23, Issue 3, 2001, Pages 268-276

  Lee, Jean W ^a   Petersen, Mary E ^a   Lin, Patrick ^a   Dressler, Dawna ^b   Bekersky, Ihor ^c  

^a MDS Inc   (Canada)

^b DUPONT COMPANY   (United States)

^c Fujisawa Health Care Inc   (United States)

Author keywords

Amphotericin B, free and bound; Biologic matrices; Liquid chromatography tandem mass spectrometry

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; NATAMYCIN;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FECES LEVEL; DRUG STABILITY; DRUG STRUCTURE; DRUG URINE LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; METHODOLOGY; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY;

EID: 0035014441     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200106000-00015     Document Type: Article

References (24)

1. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990;12:308-29.
2. Bekersky I, Fielding RM, Buell D, Lawrence I. Lipid-based amphotericin B formulations: from animals to man. Pharmaceut Sci Technol Today 1999;2:230-6.
3. Boswell GW, Buell D, Bekersky I. AmBisome (liposomal amphotericin B): A comparative review. J Clin Pharmacol 1998;38: 583-92.
4. Fielding RM, Singer AW, Wang LH, et al. Relationship of pharmacokinetics and drug distribution in tissue to increased safety of colloidal dispersion amphotencin B in dogs. Antimicrob Agents Chemother 1992;36:299-307.
5. Fielding RM, Lewis RO, Moon-McDermott L. Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MikKasome). Pharm Res 1998;15: 1775-1778.
6. Nilsson-Ehle I, Yoshikawa TT, Edward JE, et al. Quantitation of amphotericin B with use of high-pressure liquid chromatography. J Infect Dis 1977;135:414-22.
7. Mayhew JW, Fiore C, Murray T, et al. An internally-standardized assay for amphotericin B in tissues and plasma. J Chromatogr 1983;274:271-9.
8. Leclercq M, Fouillit M, Panteix G. Reproducible measurement of amphotericin B in serum by high-performance liquid chromatography in alkaline buffer. J Chromatogr 1985;337:423-8.
9. Granich GG, Kobayashi GS, Krogstand DJ. Sensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standard. Antimicrob Agents Chemother 1986;29:584-8.
10. Bach PR. Quantitative extraction of amphotencin B from serum and its determination by high-pressure liquid chromatography. Antimicrob Agents Chemother 1984;26:314-7.
11. Golas CL, Prober CG, Macleod SM, Soldin SJ. Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography. J Chromatogr 1983;278:387-95.
12. Brassinne C, Laduron C, Coune A et al. High-performance liquid chromatographic determination of amphotericin B in serum. J Chromatogr 1987;419:401-7.
13. Hosotsubo H, Hosotsubo K. Improved high-performance liquid chromatographic determination of amphotericin B in human serum and plasma. J Pharm Biomed Anal 1989;7:975-9.
14. Wang LH, Smith PC, Anderson. High-performance liquid chromatographic analysis of amphotericin B in plasma, blood, urine and tissues for pharmacokinetic and tissue distribution studies. J Chromatogr 1992;579:259-68.
15. Liu H, Davoudi H, Last T. Determination of amphotericin B in cerebrospinal fluid by solid-phase extraction and liquid chromatography. J Pharm Biomed Anal 1995;13:1395-400.
16. Lambros MP, Abbas SA, Bourne DWA. New high-performance liquid chromatographic method for amphotericin B analysis using an internal standard. J Chromatogr 1996;685:135-40.
17. Alak A, Moy S, Bekersky I. A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation. Ther Drug Monit 1996;18:604-9.
18. Monteil CG, Kergueris, Iooss P, et al. Quantitation of amphotericin B in plasma by second-derivative spectrophotometry. J Pharm Biomed Anal 1998;17:481-5.
19. Kobayashi K, Sakoguchi T, Fujiwara K, et al. High-performance liquid chromatographic determination of amphotericin B in human urine. J Chromatogr 1987;417:439-46.
20. Buhrman DL, Price PI, Rudewicz PJ. Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry. A study of ion suppression. J Am Mass Spectrom 1996;7:1099.
21. Matuszewski BK, Constanzer ML, Charez-Eng CM. Matrix effect in quantitative LS/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter. Anal Chem 1998;70:882.
22. Fujisawa HealthCare Inc. AmBisome (amphotericin B) liposome for injection. In: Physicians Desk Reference. 54th ed. Montvale, NJ: Medical Economics Co.; 2000:1090-4.
23. Shah VP, Midah KK, Digne S, et al. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J Pharm Sci 1992;81:309.
24. Beggs WH, Kinetics of amphotericin B decay in a liquid medium and characterization of the decay process. Curr Microbiol 1978;1: 301-4.